PENGLOBE TAB 800 MG DIN 00627135
Health Canada record
| Active ingredient(s) | BACAMPICILLIN HYDROCHLORIDE 800 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CA06 BACAMPICILLIN |
| Original market date | 31-Dec-1984 |
| Current status date | 20-Jul-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
AstraZeneca Canada Inc. — licence 100421, currently licensed, last inspection rating C (2023-06-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BACAMPICILLIN HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00627127 | PENGLOBE TAB 400 MG | ASTRAZENECA CANADA INC | Tablet | BACAMPICILLIN HYDROCHLORIDE 400 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 998 | 2000-04-19 | New Drug Submission (NDS) |
International API supply for BACAMPICILLIN HYDROCHLORIDE
1 valid EDQM Certificates of Suitability from 1 holders. 0 active FDA Drug Master Files.
Request a quote for PENGLOBE TAB 800 MG